31 completed, 29 withdrawn, 12 unknown, 8 not yet recruiting. 71 Phase 3, 9 Phase 2, 5 Phase 4, 3 Not applicable.
Follow EMS: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate DEP114 for the Treatment of Acute Exacerbation of Persistent Allergic Rhinitis in Children Aged 6 to Under 12 Years DEP114, Desloratadine - Persistent Allergic Rhinitis | Phase 3 | Not yet recruiting | EMS | 316 | 2027-06-01 | 2026-09-22 |
| A Study to Investigate Efficacy and Safety of a TCA108 in Participants ≥18 Years With Uncontrolled Hypertension TCA108, Bramicar HCT, Micardis Anlo - Hypertension | Phase 3 | Not yet recruiting | EMS | 400 | 2026-11-01 | 2026-07-10 |
| Efficacy and Safety of Canadá Association in the Treatment of Chronic Pain Canadá, Canadá placebo, Dipyrone - Pain, Chronic | Phase 2 | Withdrawn | EMS | 2026-09-01 | 2023-09-08 | |
| Efficacy and Safety of CDE100 in the Treatment of Menstrual Cramp Pain Associated With Primary Dysmenorrhea CDE100 association, Buscopan® Composto association - Primary Dysmenorrhea | Phase 3 | Recruiting | EMS | 238 | 2025-06-11 | 2025-12-08 |
| Efficacy and Safety of DIT112 in the Treatment of Moderate to Severe Pain After Dental Surgery for the Extraction of Impacted Third Molars DIT112, DIPYRONE, TRAMADOL - Moderate Pain, Severe Pain | Phase 3 | Not yet recruiting | EMS | 252 | 2025-02-15 | 2024-02-20 |
| Efficacy and Safety of DEP114 in the Treatment of Moderate to Severe Persistent Allergic Rhinitis in Children. DEP114, Desloratadine 0.5 MG/ML - Allergic Rhinitis | Phase 3 | Not yet recruiting | EMS | 318 | 2025-02-15 | 2024-02-22 |
| Efficacy and Safety of DEH113 in the Treatment of Menstrual Cramp Pain Associated With Primary Dysmenorrhea DEH113, Placebo Comparator - Primary Dysmenorrhea | Phase 3 | Not yet recruiting | EMS | 78 | 2025-02-01 | 2024-02-22 |
| Efficacy and Safety of the DTT106 in the Treatment of Erectile Dysfunction Associated With Benign Prostatic Hyperplasia DTT106, Dutasteride-Tamsulosin - Prostatic Hyperplasia, Benign, Erectile Dysfunction | Phase 3 | Not yet recruiting | EMS | 262 | 2025-02-01 | 2024-02-20 |
| Efficacy and Safety of OMA102 in the Treatment of Female Pattern Hair Loss OMA102, Placebo - Female Pattern Baldness | Phase 3 | Not yet recruiting | EMS | 504 | 2025-01-01 | 2024-02-16 |
| Efficacy and Safety of Madalena Association in the Treatment of Type II Diabetes Mellitus MADALENA ASSOCIATION, METFORMIN, EMPAGLIFLOZIN + LINAGLIPTIN - Type 2 Diabetes Mellitus | Phase 3 | Recruiting | EMS | 270 | 2024-11-18 | 2025-12-08 |
| Efficacy and Safety of Piemonte Association in the Treatment of Type II Diabetes Mellitus PIEMONTE, PIEMONTE PLACEBO, EMPAGLIFLOZIN - Type II Diabetes | Phase 3 | Recruiting | EMS | 480 | 2024-10-08 | 2025-12-08 |
| Efficacy and Safety of BALI Association in the Treatment of Aphthous Ulcerations BALI association, Placebo - Aphthous Stomatitis | Phase 3 | Unknown | EMS | 232 | 2024-09-01 | 2024-02-16 |
| Efficacy and Safety of DEH113 in the Treatment of Menstrual Cramp Pain in Primary Dysmenorrhea: a Pilot Study DEH113, Placebo - Primary Dysmenorrhea | Not applicable | Unknown | EMS | 60 | 2024-09-01 | 2024-08-15 |
| Efficacy and Safety of MAZ-101 in the Treatment of Persistent Allergic Rhinitis (PER) MAZ-101association, DYMISTA® - Allergic Rhinitis | Phase 3 | Unknown | EMS | 514 | 2024-09-01 | 2024-02-16 |
| Efficacy and Safety of Toronto Association in the Treatment of Erectile Dysfunction and Premature Ejaculation Toronto association, Tadalafil, Tadalafil placebo - Erectile Dysfunction, Premature Ejaculation | Phase 3 | Unknown | EMS | 232 | 2024-07-01 | 2023-04-12 |
| Safety and Efficacy of Zolpidem in the Long-Term Treatment of Insomnia Sublingual Tablet - Chronic Insomnia | Phase 3 | Unknown | EMS | 358 | 2024-06-01 | 2023-09-07 |
| Efficacy and Safety of LID104 in the Treatment of Type II Diabetes Mellitus LID104, Dapagliflozin, Linagliptin - Type 2 Diabetes Mellitus | Phase 3 | Not yet recruiting | EMS | 597 | 2024-02-01 | 2023-06-02 |
| Efficacy and Safety of BNP105 in the Treatment of Recurrent Aphthous Stomatitis BNP105 (25 + 25 + 15), Placebo - Aphthous Stomatitis | Not applicable | Unknown | EMS | 102 | 2024-01-22 | 2024-02-20 |
| Efficacy and Safety of Berlim 25/20 Association in the Treatment of Type II Diabetes Mellitus and Dyslipidemia. BERLIM 25/20 ASSOCIATION, EMPAGLIFLOZIN PLACEBO, ROSUVASTATIN CALCIUM PLACEBO - Dyslipidemia Associated With Type II Diabetes Mellitus | Phase 3 | Recruiting | EMS | 228 | 2023-12-01 | 2025-12-08 |
| Efficacy and Safety of DEC103 in Pain Control Associated to Intrauterine Device (IUD) Insertion DEC103, Placebo DEC103 - Pain | Phase 4 | Completed | EMS | 120 | 2023-09-03 | 2024-02-20 |
Showing 20 of 88. Sign in to see all of them.
Hypertension (9) · Diabetes Mellitus, Type 2 (8) · Rhinitis, Allergic (7) · Dyslipidemias (6) · Common Cold (4) · Erectile Dysfunction (3) · Sleep Initiation and Maintenance Disorders (3) · Acute Pain (2) · Alopecia (2) · Asthma (2) · Back Pain (2) · Coronavirus Infections (2) · Dermatitis (2) · Dermatitis, Atopic (2) · Dyspepsia (2)
Rosuvastatin Calcium (5) · desloratadine (5) · empagliflozin (5) · Betamethasone (4) · Chlorthalidone (4) · Prednisolone (4) · Acyclovir (3) · Dipyrone (3) · Esomeprazole (3) · Ketorolac Tromethamine (3) · Linagliptin (3) · Mometasone Furoate (3) · Naproxen (3) · Tramadol (3) · dexchlorpheniramine (3)
Brazil (52) · Egypt (1) · Portugal (1)
Felipe Pinho, MD (8) · Flavia Addor, MD (2) · Alexandre Biasi, PhD (1) · Ana Isabel Moreira (1) · Carlos Fernando Francesconi, MD (1) · Cassiano Berto (1) · Dalva R Poyares, MD (1) · Decio Chinzon, Phd (1) · Joyce Silva, MD (1) · Luis G Bahamondes, MD (1)
PMID 36472162, PMID 38104755, PMID 22463723, PMID 27382251, PMID 29746903, PMID 30233140, PMID 31859791, PMID 32386744, PMID 32706953, PMID 32896292